Enable Biosciences is a biotech company that develops ultrasensitive immunoassays permitting early detection and treatment of autoimmune and infectious diseases. It offers Antibody Detection by Agglutination PCR (ADAP), a technology that couples specific DNA tags with antigens used to detect antibodies in blood, saliva, or other bodily fluids.